Stoke Therapeutics Inc. (STOK) NASDAQ
$14 (0.13) (-0.92%)
Market Cap: $736.45M
As of 05/16/24 03:59 PM EDT. Market closed.
Stoke Therapeutics Inc. (STOK)
NASDAQ
$14
(0.13) (-0.92%)
Market Cap: $736.45M
As of 05/16/24 03:59 PM EDT. Market closed.
Add to Portfolio
stoke is developing antisense oligonucleotide medicines that target rna splicing to increase gene expression for the treatment of severe genetic ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Edward Kaye
Full Time Employees
113
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Edward Kaye
Full Time Employees
113
Address
3 Preston Ct, Massachusetts, Bedford, 01730-2379.
PRICE CHART FOR STOKE THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$14.05
Previous Close
$14.13
Days Range
$13.17 - $14.80
52 week range
$3.35 - $16.40
Volume
762,675
Avg. Volume (30 days)
848,271
Market Cap
$736.45M
Dividend Yield
-
P/E
(6.79)
Shares Outstanding
52,119,860
Open
$14.05
Previous Close
$14.13
Days Range
$13.17 - $14.80
52 week range
$3.35 - $16.40
Volume
762,675
Avg. Volume (30 days)
848,271
Market Cap
$736.45M
Dividend Yield
-
P/E
(6.79)
Shares Outstanding
52,119,860
FINANCIAL STATEMENTS FOR STOKE THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR STOKE THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Ticho Barry | CHIEF MEDICAL OFFICER | May 01, 2024 | Option Exercise | $0.60 | 10,000 | 6,000 | 12,485 | May 03, 2024, 04:24 PM |
| Ticho Barry | CHIEF MEDICAL OFFICER | May 01, 2024 | Sale | $11.37 | 10,000 | 113,653 | 2,485 | May 03, 2024, 04:24 PM |
| Skorpios Trust | 10% Owner | Apr 17, 2024 | Sale | $11.60 | 3,600,000 | 41,760,001 | 10,843,681 | Apr 18, 2024, 04:16 PM |
| Ticho Barry | CHIEF MEDICAL OFFICER | Apr 01, 2024 | Option Exercise | $0.60 | 442 | 265 | 11,911 | Apr 03, 2024, 04:21 PM |
| Ticho Barry | CHIEF MEDICAL OFFICER | Apr 01, 2024 | Sale | $13.23 | 9,426 | 124,684 | 2,485 | Apr 03, 2024, 04:21 PM |
| Allan Jonathan | GENERAL COUNSEL & CORP SEC | Mar 28, 2024 | Sale | $13.20 | 5,126 | 67,668 | 2,698 | Apr 01, 2024, 04:14 PM |
| Tulipano Stephen J | CFO | Mar 19, 2024 | Sale | $6.10 | 4,116 | 25,102 | 20,746 | Mar 19, 2024, 08:36 PM |
| Ticho Barry | CHIEF MEDICAL OFFICER | Mar 19, 2024 | Sale | $6.10 | 4,116 | 25,102 | 11,469 | Mar 19, 2024, 08:34 PM |
| Nash Huw M. | COO & CBO | Mar 19, 2024 | Sale | $6.10 | 4,116 | 25,102 | 11,329 | Mar 19, 2024, 08:31 PM |
| Kaye Edward M. MD | CEO | Mar 19, 2024 | Sale | $6.10 | 11,150 | 67,999 | 69,350 | Mar 19, 2024, 08:30 PM |
| Allan Jonathan | GENERAL COUNSEL & CORP SEC | Mar 19, 2024 | Sale | $6.10 | 2,349 | 14,326 | 7,724 | Mar 19, 2024, 08:29 PM |
| Ticho Barry | CHIEF MEDICAL OFFICER | Mar 01, 2024 | Option Exercise | $0.60 | 5,504 | 3,302 | 12,485 | Mar 05, 2024, 04:21 PM |
| Ticho Barry | CHIEF MEDICAL OFFICER | Mar 01, 2024 | Sale | $7.75 | 10,000 | 77,469 | 2,485 | Mar 05, 2024, 04:21 PM |
| TZIANABOS ARTHUR | Director | Feb 13, 2024 | Option Exercise | $2.19 | 31,739 | 69,508 | 31,739 | Feb 15, 2024, 04:17 PM |
| Ticho Barry | CHIEF MEDICAL OFFICER | Feb 01, 2024 | Sale | $4.80 | 10,000 | 47,991 | 6,981 | Feb 05, 2024, 04:32 PM |
| Kaye Edward M. MD | CEO | Mar 27, 2023 | Option Exercise | $0.60 | 20,000 | 12,000 | 45,000 | Sep 08, 2023, 04:15 PM |
| Ticho Barry | Chief Medical Officer | Jul 03, 2023 | Sale | $10.60 | 15,000 | 158,973 | 25,895 | Jul 06, 2023, 05:20 PM |
| Allan Jonathan | General Counsel & Corp Sec | Jun 21, 2023 | Sale | $13.48 | 1,948 | 26,252 | 0 | Jun 23, 2023, 04:45 PM |
| Ticho Barry | Chief Medical Officer | Jun 01, 2023 | Sale | $11.13 | 15,000 | 166,964 | 40,895 | Jun 05, 2023, 07:31 PM |
| Ticho Barry | Chief Medical Officer | May 04, 2023 | Sale | $10.00 | 653 | 6,530 | 55,895 | May 08, 2023, 07:35 PM |
| Ticho Barry | Chief Medical Officer | May 03, 2023 | Sale | $10.14 | 24,697 | 250,366 | 56,548 | May 03, 2023, 08:04 PM |
| Ticho Barry | Chief Medical Officer | May 02, 2023 | Sale | $10.00 | 5,513 | 55,134 | 81,245 | May 03, 2023, 08:04 PM |
| Ticho Barry | Chief Medical Officer | May 01, 2023 | Sale | $10.00 | 24,967 | 249,767 | 86,758 | May 03, 2023, 08:04 PM |
| Ticho Barry | Chief Medical Officer | Feb 06, 2023 | Sale | $10.02 | 9,235 | 92,491 | 111,725 | Feb 07, 2023, 05:08 PM |
| Ticho Barry | Chief Medical Officer | Feb 03, 2023 | Sale | $10.03 | 3,763 | 37,745 | 120,960 | Feb 07, 2023, 05:08 PM |
| Ticho Barry | Chief Medical Officer | Feb 02, 2023 | Sale | $10.00 | 267 | 2,670 | 124,723 | Feb 02, 2023, 06:32 PM |
| Ticho Barry | Chief Medical Officer | Feb 01, 2023 | Sale | $10.02 | 5,705 | 57,140 | 124,990 | Feb 02, 2023, 06:32 PM |
| Ticho Barry | Chief Medical Officer | Jan 31, 2023 | Sale | $10.00 | 200 | 2,000 | 130,695 | Feb 02, 2023, 06:32 PM |
| Tulipano Stephen J | CFO | Jun 02, 2022 | Option Exercise | $4.48 | 11,160 | 49,997 | 11,762 | Jun 03, 2022, 05:00 PM |
| Kaye Edward M. MD | CEO | May 25, 2022 | Option Exercise | $0.60 | 15,000 | 9,000 | 25,000 | May 26, 2022, 05:16 PM |
| Nash Huw M. | COO & CBO | Jan 03, 2022 | Option Exercise | $2.19 | 3,800 | 8,322 | 3,800 | Jan 05, 2022, 05:35 PM |
| Nash Huw M. | COO & CBO | Jan 03, 2022 | Sale | $23.07 | 3,800 | 87,666 | 2,303 | Jan 05, 2022, 05:35 PM |
| Nash Huw M. | COO & CBO | Dec 01, 2021 | Option Exercise | $2.19 | 5,700 | 12,483 | 5,700 | Dec 03, 2021, 06:15 PM |
| Nash Huw M. | COO & CBO | Dec 01, 2021 | Sale | $24.44 | 5,700 | 139,330 | 2,500 | Dec 03, 2021, 06:15 PM |
| Nash Huw M. | COO & CBO | Nov 01, 2021 | Option Exercise | $2.19 | 3,800 | 8,322 | 3,800 | Nov 03, 2021, 06:05 PM |
| Nash Huw M. | COO & CBO | Nov 03, 2021 | Option Exercise | $2.19 | 1,900 | 4,161 | 1,900 | Nov 03, 2021, 06:05 PM |
| Nash Huw M. | COO & CBO | Nov 01, 2021 | Sale | $23.54 | 3,800 | 89,456 | 1,610 | Nov 03, 2021, 06:05 PM |
| Nash Huw M. | COO & CBO | Nov 03, 2021 | Sale | $25.00 | 1,900 | 47,500 | 0 | Nov 03, 2021, 06:05 PM |
| Nash Huw M. | COO & CBO | Oct 01, 2021 | Option Exercise | $2.19 | 5,700 | 12,483 | 5,700 | Oct 04, 2021, 05:51 PM |
| Nash Huw M. | COO & CBO | Oct 01, 2021 | Sale | $24.83 | 5,700 | 141,506 | 0 | Oct 04, 2021, 05:51 PM |
| Nash Huw M. | COO & CBO | Sep 01, 2021 | Option Exercise | $2.19 | 5,700 | 12,483 | 5,700 | Sep 02, 2021, 06:30 PM |
| Nash Huw M. | COO & CBO | Sep 01, 2021 | Sale | $26.00 | 5,700 | 148,223 | 0 | Sep 02, 2021, 06:30 PM |
| Nash Huw M. | COO & CBO | Aug 02, 2021 | Option Exercise | $2.19 | 5,700 | 12,483 | 5,700 | Aug 04, 2021, 07:41 PM |
| Nash Huw M. | COO & CBO | Aug 02, 2021 | Sale | $28.87 | 5,700 | 164,554 | 0 | Aug 04, 2021, 07:41 PM |
| Ticho Barry | Chief Medical Officer | Jul 13, 2021 | Sale | $32.75 | 43,166 | 1,413,654 | 134,195 | Jul 15, 2021, 07:29 PM |
| Nash Huw M. | COO & CBO | Jul 01, 2021 | Option Exercise | $2.19 | 5,700 | 12,483 | 5,700 | Jul 02, 2021, 05:41 PM |
| Nash Huw M. | COO & CBO | Jul 01, 2021 | Sale | $33.33 | 5,700 | 189,987 | 0 | Jul 02, 2021, 05:41 PM |
| Nash Huw M. | COO & CBO | Jun 01, 2021 | Option Exercise | $2.19 | 575 | 1,259 | 575 | Jun 03, 2021, 05:48 PM |
| Nash Huw M. | COO & CBO | Jun 01, 2021 | Sale | $39.43 | 575 | 22,669 | 0 | Jun 03, 2021, 05:48 PM |
| Liau Gene | EVP Research & Preclinical Dev | Mar 02, 2021 | Option Exercise | $0.60 | 5,195 | 3,117 | 26,546 | Mar 04, 2021, 05:00 PM |
| Liau Gene | EVP Research & Preclinical Dev | Dec 28, 2020 | Option Exercise | $0.60 | 8,000 | 4,800 | 21,500 | Mar 04, 2021, 05:00 PM |
| Liau Gene | EVP Research & Preclinical Dev | Mar 02, 2021 | Sale | $63.05 | 5,195 | 327,546 | 24,251 | Mar 04, 2021, 05:00 PM |
| Liau Gene | EVP Research & Preclinical Dev | Dec 28, 2020 | Sale | $58.73 | 149 | 8,751 | 21,351 | Mar 04, 2021, 05:00 PM |
| LEVIN ARTHUR A | Director | Mar 01, 2021 | Option Exercise | $0.53 | 12,500 | 6,576 | 12,500 | Mar 03, 2021, 05:10 PM |
| LEVIN ARTHUR A | Director | Mar 01, 2021 | Sale | $60.79 | 12,500 | 759,841 | 4,957 | Mar 03, 2021, 05:10 PM |
| Tulipano Stephen J | CFO | Feb 23, 2021 | Option Exercise | $4.48 | 5,000 | 22,400 | 5,602 | Feb 24, 2021, 05:15 PM |
| Tulipano Stephen J | CFO | Feb 22, 2021 | Option Exercise | $4.48 | 25,000 | 112,000 | 25,602 | Feb 24, 2021, 05:15 PM |
| Tulipano Stephen J | CFO | Feb 23, 2021 | Sale | $58.60 | 5,000 | 292,992 | 602 | Feb 24, 2021, 05:15 PM |
| Tulipano Stephen J | CFO | Feb 22, 2021 | Sale | $58.92 | 25,000 | 1,472,904 | 10,400 | Feb 24, 2021, 05:15 PM |
| TZIANABOS ARTHUR | Director | Feb 19, 2021 | Option Exercise | $2.19 | 10,000 | 21,900 | 10,000 | Feb 23, 2021, 05:28 PM |
| TZIANABOS ARTHUR | Director | Feb 19, 2021 | Sale | $60.67 | 10,000 | 606,652 | 0 | Feb 23, 2021, 05:28 PM |
| Nash Huw M. | COO & CBO | Jan 04, 2021 | Option Exercise | $2.19 | 5,700 | 12,483 | 5,732 | Jan 06, 2021, 05:26 PM |
| Nash Huw M. | COO & CBO | Jan 06, 2021 | Sale | $57.14 | 32 | 1,828 | 0 | Jan 06, 2021, 05:26 PM |
| Nash Huw M. | COO & CBO | Jan 04, 2021 | Sale | $58.97 | 5,700 | 336,157 | 4,232 | Jan 06, 2021, 05:26 PM |
| Kaye Edward M. MD | CEO | Dec 30, 2020 | Option Exercise | $0.60 | 10,000 | 6,000 | 10,000 | Jan 04, 2021, 06:33 PM |
| Ticho Barry | Chief Medical Officer | Dec 21, 2020 | Option Exercise | $2.19 | 1,365 | 2,989 | 174,767 | Dec 21, 2020, 04:53 PM |
| Ticho Barry | Chief Medical Officer | Dec 21, 2020 | Sale | $57.62 | 1,365 | 78,654 | 174,053 | Dec 21, 2020, 04:53 PM |
| Nash Huw M. | COO & CBO | Dec 18, 2020 | Option Exercise | $0.60 | 8,015 | 4,809 | 8,015 | Dec 18, 2020, 09:08 PM |
| Nash Huw M. | COO & CBO | Dec 17, 2020 | Option Exercise | $0.60 | 41,985 | 25,191 | 41,985 | Dec 18, 2020, 09:08 PM |
| Nash Huw M. | COO & CBO | Dec 17, 2020 | Sale | $60.00 | 41,985 | 2,519,100 | 0 | Dec 18, 2020, 09:08 PM |
| Nash Huw M. | COO & CBO | Dec 18, 2020 | Sale | $60.00 | 8,015 | 480,900 | 0 | Dec 18, 2020, 09:08 PM |
| Kaye Edward M. MD | CEO | Dec 18, 2020 | Sale | $60.00 | 5,194 | 311,640 | 0 | Dec 18, 2020, 09:07 PM |
| Kaye Edward M. MD | CEO | Dec 17, 2020 | Sale | $60.00 | 19,806 | 1,188,360 | 5,194 | Dec 18, 2020, 09:07 PM |
| Nash Huw M. | COO & CBO | Dec 01, 2020 | Option Exercise | $2.19 | 5,700 | 12,483 | 5,700 | Dec 03, 2020, 06:00 PM |
| Nash Huw M. | COO & CBO | Dec 01, 2020 | Sale | $49.84 | 5,700 | 284,080 | 2,981 | Dec 03, 2020, 06:00 PM |
| Kaye Edward M. MD | CEO | Nov 27, 2020 | Sale | $50.00 | 12,152 | 607,600 | 25,000 | Nov 30, 2020, 05:11 PM |
| Kaye Edward M. MD | CEO | Nov 25, 2020 | Sale | $50.00 | 12,848 | 642,400 | 37,152 | Nov 25, 2020, 05:16 PM |
| TZIANABOS ARTHUR | Director | Nov 23, 2020 | Option Exercise | $2.19 | 20,000 | 43,800 | 20,000 | Nov 25, 2020, 05:09 PM |
| TZIANABOS ARTHUR | Director | Nov 23, 2020 | Sale | $46.03 | 20,000 | 920,566 | 15,700 | Nov 25, 2020, 05:09 PM |
| Harrison Seth Loring | Director | Nov 24, 2020 | Buy | $39.00 | 375,000 | 14,625,000 | 17,161,713 | Nov 25, 2020, 05:03 PM |
| Apple Tree Partners IV, L.P. | 10% Owner | Nov 24, 2020 | Buy | $39.00 | 375,000 | 14,625,000 | 17,161,713 | Nov 25, 2020, 05:01 PM |
| Nash Huw M. | COO & CBO | Nov 10, 2020 | Option Exercise | $1.03 | 50,000 | 51,328 | 50,000 | Nov 10, 2020, 05:42 PM |
| Nash Huw M. | COO & CBO | Nov 10, 2020 | Sale | $45.00 | 50,000 | 2,250,000 | 0 | Nov 10, 2020, 05:42 PM |
| Tulipano Stephen J | CFO | Nov 03, 2020 | Option Exercise | $4.48 | 1,732 | 7,759 | 2,334 | Nov 04, 2020, 05:31 PM |
| Tulipano Stephen J | CFO | Nov 02, 2020 | Option Exercise | $4.48 | 35,000 | 156,800 | 35,602 | Nov 04, 2020, 05:31 PM |
| Tulipano Stephen J | CFO | Nov 04, 2020 | Option Exercise | $4.48 | 33,268 | 149,041 | 33,870 | Nov 04, 2020, 05:31 PM |
| Tulipano Stephen J | CFO | Nov 03, 2020 | Sale | $39.84 | 1,732 | 68,998 | 602 | Nov 04, 2020, 05:31 PM |
| Tulipano Stephen J | CFO | Nov 02, 2020 | Sale | $37.25 | 35,000 | 1,303,731 | 15,447 | Nov 04, 2020, 05:31 PM |
| Tulipano Stephen J | CFO | Nov 04, 2020 | Sale | $40.80 | 33,268 | 1,357,210 | 16,929 | Nov 04, 2020, 05:31 PM |
| Nash Huw M. | COO & CBO | Nov 02, 2020 | Option Exercise | $2.19 | 5,700 | 12,483 | 5,700 | Nov 04, 2020, 05:30 PM |
| Nash Huw M. | COO & CBO | Nov 02, 2020 | Sale | $37.21 | 5,700 | 212,110 | 2,536 | Nov 04, 2020, 05:30 PM |
| Liau Gene | EVP Research & Preclinical Dev | Oct 19, 2020 | Option Exercise | $0.67 | 32,000 | 21,590 | 45,500 | Oct 20, 2020, 04:52 PM |
| Liau Gene | EVP Research & Preclinical Dev | Oct 16, 2020 | Option Exercise | $0.60 | 5,851 | 3,511 | 19,351 | Oct 20, 2020, 04:52 PM |
| Liau Gene | EVP Research & Preclinical Dev | Oct 16, 2020 | Sale | $40.00 | 5,851 | 234,042 | 13,500 | Oct 20, 2020, 04:52 PM |
| Liau Gene | EVP Research & Preclinical Dev | Oct 19, 2020 | Sale | $37.82 | 32,000 | 1,210,164 | 20,725 | Oct 20, 2020, 04:52 PM |
| Liau Gene | EVP Research & Preclinical Dev | Oct 13, 2020 | Option Exercise | $0.60 | 1,649 | 989 | 15,149 | Oct 13, 2020, 05:43 PM |
| Liau Gene | EVP Research & Preclinical Dev | Oct 13, 2020 | Sale | $40.00 | 1,649 | 65,960 | 13,500 | Oct 13, 2020, 05:43 PM |
| Nash Huw M. | COO & CBO | Oct 01, 2020 | Option Exercise | $2.19 | 5,700 | 12,483 | 5,700 | Oct 05, 2020, 05:12 PM |
| Nash Huw M. | COO & CBO | Oct 01, 2020 | Sale | $34.54 | 5,700 | 196,901 | 2,300 | Oct 05, 2020, 05:12 PM |
| Nash Huw M. | COO & CBO | Sep 09, 2020 | Option Exercise | $2.19 | 17,201 | 37,670 | 17,201 | Sep 10, 2020, 06:21 PM |
| Nash Huw M. | COO & CBO | Sep 08, 2020 | Option Exercise | $2.19 | 30,718 | 67,272 | 30,718 | Sep 10, 2020, 06:21 PM |
| Nash Huw M. | COO & CBO | Sep 09, 2020 | Sale | $30.00 | 17,201 | 516,030 | 0 | Sep 10, 2020, 06:21 PM |
| Nash Huw M. | COO & CBO | Sep 08, 2020 | Sale | $30.00 | 30,718 | 921,540 | 0 | Sep 10, 2020, 06:21 PM |
| Nash Huw M. | COO & CBO | Sep 01, 2020 | Option Exercise | $2.19 | 5,700 | 12,483 | 5,700 | Sep 03, 2020, 06:35 PM |
| Nash Huw M. | COO & CBO | Sep 01, 2020 | Sale | $27.74 | 5,700 | 158,113 | 700 | Sep 03, 2020, 06:35 PM |
| Nash Huw M. | COO & CBO | Aug 28, 2020 | Option Exercise | $2.19 | 2,081 | 4,557 | 2,081 | Aug 31, 2020, 06:04 PM |
| Nash Huw M. | COO & CBO | Aug 28, 2020 | Sale | $30.00 | 2,081 | 62,430 | 0 | Aug 31, 2020, 06:04 PM |
| Nash Huw M. | COO & CBO | Aug 03, 2020 | Option Exercise | $2.19 | 5,700 | 12,483 | 5,700 | Aug 04, 2020, 04:59 PM |
| Nash Huw M. | COO & CBO | Aug 03, 2020 | Sale | $24.73 | 5,700 | 140,943 | 0 | Aug 04, 2020, 04:59 PM |
| Nash Huw M. | COO & CBO | Jul 16, 2020 | Option Exercise | $2.19 | 1,900 | 4,161 | 1,900 | Jul 17, 2020, 06:02 PM |
| Nash Huw M. | COO & CBO | Jul 16, 2020 | Sale | $25.06 | 1,900 | 47,614 | 0 | Jul 17, 2020, 06:02 PM |
| Walker Robin A. | Chief Legal Officer, CCO & Sec | Jul 07, 2020 | Sale | $22.50 | 941 | 21,173 | 0 | Jul 09, 2020, 05:43 PM |
| Nash Huw M. | COO & CBO | Jul 07, 2020 | Sale | $22.41 | 913 | 20,457 | 0 | Jul 09, 2020, 05:41 PM |
| Nash Huw M. | COO & CBO | Jul 01, 2020 | Option Exercise | $2.19 | 3,800 | 8,322 | 3,800 | Jul 02, 2020, 06:08 PM |
| Nash Huw M. | COO & CBO | Jul 01, 2020 | Sale | $23.15 | 3,800 | 87,968 | 0 | Jul 02, 2020, 06:08 PM |
| Ticho Barry | Chief Medical Officer | Jun 01, 2020 | Option Exercise | $0.99 | 174,027 | 172,595 | 174,027 | Jun 03, 2020, 04:58 PM |
| Ticho Barry | Chief Medical Officer | Jun 01, 2020 | Sale | $27.39 | 1,365 | 37,387 | 173,027 | Jun 03, 2020, 04:58 PM |
| Liau Gene | EVP Research & Preclinical Dev | Jun 01, 2020 | Option Exercise | $2.19 | 20,000 | 43,800 | 33,500 | Jun 03, 2020, 04:57 PM |
| Liau Gene | EVP Research & Preclinical Dev | Jun 01, 2020 | Sale | $26.35 | 20,000 | 527,037 | 22,605 | Jun 03, 2020, 04:57 PM |
| Nash Huw M. | COO & CBO | Jun 01, 2020 | Option Exercise | $2.19 | 2,107 | 4,614 | 2,107 | Jun 03, 2020, 04:55 PM |
| Nash Huw M. | COO & CBO | Jun 01, 2020 | Sale | $27.18 | 2,107 | 57,263 | 500 | Jun 03, 2020, 04:55 PM |
| Liau Gene | EVP Research & Preclinical Dev | May 22, 2020 | Option Exercise | $0.60 | 7,500 | 4,500 | 21,000 | May 26, 2020, 05:58 PM |
| Liau Gene | EVP Research & Preclinical Dev | May 22, 2020 | Sale | $30.00 | 7,500 | 225,000 | 13,500 | May 26, 2020, 05:58 PM |
| Liau Gene | EVP Research & Preclinical Dev | Dec 20, 2019 | Option Exercise | $0.60 | 6,000 | 3,600 | 6,000 | Apr 15, 2020, 07:33 PM |
| Liau Gene | EVP Research & Preclinical Dev | Mar 31, 2020 | Option Exercise | $0.60 | 7,500 | 4,500 | 13,500 | Apr 15, 2020, 07:33 PM |
| Kaye Edward M. MD | CEO | Dec 16, 2019 | Option Exercise | $0.60 | 50,000 | 30,000 | 50,000 | Apr 15, 2020, 07:27 PM |
| Nash Huw M. | COO & CBO | Mar 02, 2020 | Option Exercise | $1.96 | 49,103 | 96,216 | 49,103 | Mar 04, 2020, 07:25 PM |
| Nash Huw M. | COO & CBO | Mar 02, 2020 | Sale | $25.89 | 49,143 | 1,272,549 | 15,995 | Mar 04, 2020, 07:25 PM |
| RTW INVESTMENTS, LP | 10% Owner | Nov 08, 2019 | Sale | $28.70 | 16,434 | 471,631 | 3,544,248 | Nov 12, 2019, 04:42 PM |
| RTW INVESTMENTS, LP | 10% Owner | Nov 04, 2019 | Buy | $29.24 | 104,873 | 3,066,843 | 3,560,682 | Nov 06, 2019, 06:52 PM |
| RTW INVESTMENTS, LP | 10% Owner | Nov 01, 2019 | Buy | $28.61 | 8,598 | 245,950 | 3,455,809 | Nov 01, 2019, 04:55 PM |
| RTW INVESTMENTS, LP | 10% Owner | Oct 31, 2019 | Buy | $28.15 | 18,747 | 527,659 | 3,447,211 | Nov 01, 2019, 04:55 PM |
| RTW INVESTMENTS, LP | 10% Owner | Oct 30, 2019 | Buy | $28.79 | 41,438 | 1,193,004 | 3,428,464 | Nov 01, 2019, 04:55 PM |
| RTW INVESTMENTS, LP | 10% Owner | Oct 01, 2019 | Buy | $21.96 | 31,560 | 693,029 | 3,387,026 | Oct 02, 2019, 01:20 PM |
| Harrison Seth Loring | Director | Jun 21, 2019 | Buy | $18.00 | 1,388,889 | 25,000,002 | 16,786,713 | Jun 21, 2019, 05:01 PM |
| Apple Tree Partners IV, L.P. | 10% Owner | Jun 21, 2019 | Buy | $18.00 | 1,388,889 | 25,000,002 | 16,786,713 | Jun 21, 2019, 04:59 PM |
| RTW INVESTMENTS, LP | 10% Owner | Jun 19, 2019 | Buy | $18.00 | 555,556 | 10,000,008 | 3,355,466 | Jun 20, 2019, 09:50 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Ticho Barry | CHIEF MEDICAL OFFICER | 05/01/2024 | 6,000 |
| Ticho Barry | CHIEF MEDICAL OFFICER | 05/01/2024 | 113,653 |
| Skorpios Trust | 10% Owner | 04/17/2024 | 41,760,001 |
| Ticho Barry | CHIEF MEDICAL OFFICER | 04/01/2024 | 265 |
| Ticho Barry | CHIEF MEDICAL OFFICER | 04/01/2024 | 124,684 |
| Allan Jonathan | GENERAL COUNSEL & CORP SEC | 03/28/2024 | 67,668 |
| Tulipano Stephen J | CFO | 03/19/2024 | 25,102 |
| Ticho Barry | CHIEF MEDICAL OFFICER | 03/19/2024 | 25,102 |
| Nash Huw M. | COO & CBO | 03/19/2024 | 25,102 |
| Kaye Edward M. MD | CEO | 03/19/2024 | 67,999 |
| Allan Jonathan | GENERAL COUNSEL & CORP SEC | 03/19/2024 | 14,326 |
| Ticho Barry | CHIEF MEDICAL OFFICER | 03/01/2024 | 3,302 |
| Ticho Barry | CHIEF MEDICAL OFFICER | 03/01/2024 | 77,469 |
| TZIANABOS ARTHUR | Director | 02/13/2024 | 69,508 |
| Ticho Barry | CHIEF MEDICAL OFFICER | 02/01/2024 | 47,991 |
| Kaye Edward M. MD | CEO | 03/27/2023 | 12,000 |
| Ticho Barry | Chief Medical Officer | 07/03/2023 | 158,973 |
| Allan Jonathan | General Counsel & Corp Sec | 06/21/2023 | 26,252 |
| Ticho Barry | Chief Medical Officer | 06/01/2023 | 166,964 |
| Ticho Barry | Chief Medical Officer | 05/04/2023 | 6,530 |
| Ticho Barry | Chief Medical Officer | 05/03/2023 | 250,366 |
| Ticho Barry | Chief Medical Officer | 05/02/2023 | 55,134 |
| Ticho Barry | Chief Medical Officer | 05/01/2023 | 249,767 |
| Ticho Barry | Chief Medical Officer | 02/06/2023 | 92,491 |
| Ticho Barry | Chief Medical Officer | 02/03/2023 | 37,745 |
| Ticho Barry | Chief Medical Officer | 02/02/2023 | 2,670 |
| Ticho Barry | Chief Medical Officer | 02/01/2023 | 57,140 |
| Ticho Barry | Chief Medical Officer | 01/31/2023 | 2,000 |
| Tulipano Stephen J | CFO | 06/02/2022 | 49,997 |
| Kaye Edward M. MD | CEO | 05/25/2022 | 9,000 |
| Nash Huw M. | COO & CBO | 01/03/2022 | 8,322 |
| Nash Huw M. | COO & CBO | 01/03/2022 | 87,666 |
| Nash Huw M. | COO & CBO | 12/01/2021 | 12,483 |
| Nash Huw M. | COO & CBO | 12/01/2021 | 139,330 |
| Nash Huw M. | COO & CBO | 11/01/2021 | 8,322 |
| Nash Huw M. | COO & CBO | 11/03/2021 | 4,161 |
| Nash Huw M. | COO & CBO | 11/01/2021 | 89,456 |
| Nash Huw M. | COO & CBO | 11/03/2021 | 47,500 |
| Nash Huw M. | COO & CBO | 10/01/2021 | 12,483 |
| Nash Huw M. | COO & CBO | 10/01/2021 | 141,506 |
| Nash Huw M. | COO & CBO | 09/01/2021 | 12,483 |
| Nash Huw M. | COO & CBO | 09/01/2021 | 148,223 |
| Nash Huw M. | COO & CBO | 08/02/2021 | 12,483 |
| Nash Huw M. | COO & CBO | 08/02/2021 | 164,554 |
| Ticho Barry | Chief Medical Officer | 07/13/2021 | 1,413,654 |
| Nash Huw M. | COO & CBO | 07/01/2021 | 12,483 |
| Nash Huw M. | COO & CBO | 07/01/2021 | 189,987 |
| Nash Huw M. | COO & CBO | 06/01/2021 | 1,259 |
| Nash Huw M. | COO & CBO | 06/01/2021 | 22,669 |
| Liau Gene | EVP Research & Preclinical Dev | 03/02/2021 | 3,117 |
| Liau Gene | EVP Research & Preclinical Dev | 12/28/2020 | 4,800 |
| Liau Gene | EVP Research & Preclinical Dev | 03/02/2021 | 327,546 |
| Liau Gene | EVP Research & Preclinical Dev | 12/28/2020 | 8,751 |
| LEVIN ARTHUR A | Director | 03/01/2021 | 6,576 |
| LEVIN ARTHUR A | Director | 03/01/2021 | 759,841 |
| Tulipano Stephen J | CFO | 02/23/2021 | 22,400 |
| Tulipano Stephen J | CFO | 02/22/2021 | 112,000 |
| Tulipano Stephen J | CFO | 02/23/2021 | 292,992 |
| Tulipano Stephen J | CFO | 02/22/2021 | 1,472,904 |
| TZIANABOS ARTHUR | Director | 02/19/2021 | 21,900 |
| TZIANABOS ARTHUR | Director | 02/19/2021 | 606,652 |
| Nash Huw M. | COO & CBO | 01/04/2021 | 12,483 |
| Nash Huw M. | COO & CBO | 01/06/2021 | 1,828 |
| Nash Huw M. | COO & CBO | 01/04/2021 | 336,157 |
| Kaye Edward M. MD | CEO | 12/30/2020 | 6,000 |
| Ticho Barry | Chief Medical Officer | 12/21/2020 | 2,989 |
| Ticho Barry | Chief Medical Officer | 12/21/2020 | 78,654 |
| Nash Huw M. | COO & CBO | 12/18/2020 | 4,809 |
| Nash Huw M. | COO & CBO | 12/17/2020 | 25,191 |
| Nash Huw M. | COO & CBO | 12/17/2020 | 2,519,100 |
| Nash Huw M. | COO & CBO | 12/18/2020 | 480,900 |
| Kaye Edward M. MD | CEO | 12/18/2020 | 311,640 |
| Kaye Edward M. MD | CEO | 12/17/2020 | 1,188,360 |
| Nash Huw M. | COO & CBO | 12/01/2020 | 12,483 |
| Nash Huw M. | COO & CBO | 12/01/2020 | 284,080 |
| Kaye Edward M. MD | CEO | 11/27/2020 | 607,600 |
| Kaye Edward M. MD | CEO | 11/25/2020 | 642,400 |
| TZIANABOS ARTHUR | Director | 11/23/2020 | 43,800 |
| TZIANABOS ARTHUR | Director | 11/23/2020 | 920,566 |
| Harrison Seth Loring | Director | 11/24/2020 | 14,625,000 |
| Apple Tree Partners IV, L.P. | 10% Owner | 11/24/2020 | 14,625,000 |
| Nash Huw M. | COO & CBO | 11/10/2020 | 51,328 |
| Nash Huw M. | COO & CBO | 11/10/2020 | 2,250,000 |
| Tulipano Stephen J | CFO | 11/03/2020 | 7,759 |
| Tulipano Stephen J | CFO | 11/02/2020 | 156,800 |
| Tulipano Stephen J | CFO | 11/04/2020 | 149,041 |
| Tulipano Stephen J | CFO | 11/03/2020 | 68,998 |
| Tulipano Stephen J | CFO | 11/02/2020 | 1,303,731 |
| Tulipano Stephen J | CFO | 11/04/2020 | 1,357,210 |
| Nash Huw M. | COO & CBO | 11/02/2020 | 12,483 |
| Nash Huw M. | COO & CBO | 11/02/2020 | 212,110 |
| Liau Gene | EVP Research & Preclinical Dev | 10/19/2020 | 21,590 |
| Liau Gene | EVP Research & Preclinical Dev | 10/16/2020 | 3,511 |
| Liau Gene | EVP Research & Preclinical Dev | 10/16/2020 | 234,042 |
| Liau Gene | EVP Research & Preclinical Dev | 10/19/2020 | 1,210,164 |
| Liau Gene | EVP Research & Preclinical Dev | 10/13/2020 | 989 |
| Liau Gene | EVP Research & Preclinical Dev | 10/13/2020 | 65,960 |
| Nash Huw M. | COO & CBO | 10/01/2020 | 12,483 |
| Nash Huw M. | COO & CBO | 10/01/2020 | 196,901 |
| Nash Huw M. | COO & CBO | 09/09/2020 | 37,670 |
| Nash Huw M. | COO & CBO | 09/08/2020 | 67,272 |
| Nash Huw M. | COO & CBO | 09/09/2020 | 516,030 |
| Nash Huw M. | COO & CBO | 09/08/2020 | 921,540 |
| Nash Huw M. | COO & CBO | 09/01/2020 | 12,483 |
| Nash Huw M. | COO & CBO | 09/01/2020 | 158,113 |
| Nash Huw M. | COO & CBO | 08/28/2020 | 4,557 |
| Nash Huw M. | COO & CBO | 08/28/2020 | 62,430 |
| Nash Huw M. | COO & CBO | 08/03/2020 | 12,483 |
| Nash Huw M. | COO & CBO | 08/03/2020 | 140,943 |
| Nash Huw M. | COO & CBO | 07/16/2020 | 4,161 |
| Nash Huw M. | COO & CBO | 07/16/2020 | 47,614 |
| Walker Robin A. | Chief Legal Officer, CCO & Sec | 07/07/2020 | 21,173 |
| Nash Huw M. | COO & CBO | 07/07/2020 | 20,457 |
| Nash Huw M. | COO & CBO | 07/01/2020 | 8,322 |
| Nash Huw M. | COO & CBO | 07/01/2020 | 87,968 |
| Ticho Barry | Chief Medical Officer | 06/01/2020 | 172,595 |
| Ticho Barry | Chief Medical Officer | 06/01/2020 | 37,387 |
| Liau Gene | EVP Research & Preclinical Dev | 06/01/2020 | 43,800 |
| Liau Gene | EVP Research & Preclinical Dev | 06/01/2020 | 527,037 |
| Nash Huw M. | COO & CBO | 06/01/2020 | 4,614 |
| Nash Huw M. | COO & CBO | 06/01/2020 | 57,263 |
| Liau Gene | EVP Research & Preclinical Dev | 05/22/2020 | 4,500 |
| Liau Gene | EVP Research & Preclinical Dev | 05/22/2020 | 225,000 |
| Liau Gene | EVP Research & Preclinical Dev | 12/20/2019 | 3,600 |
| Liau Gene | EVP Research & Preclinical Dev | 03/31/2020 | 4,500 |
| Kaye Edward M. MD | CEO | 12/16/2019 | 30,000 |
| Nash Huw M. | COO & CBO | 03/02/2020 | 96,216 |
| Nash Huw M. | COO & CBO | 03/02/2020 | 1,272,549 |
| RTW INVESTMENTS, LP | 10% Owner | 11/08/2019 | 471,631 |
| RTW INVESTMENTS, LP | 10% Owner | 11/04/2019 | 3,066,843 |
| RTW INVESTMENTS, LP | 10% Owner | 11/01/2019 | 245,950 |
| RTW INVESTMENTS, LP | 10% Owner | 10/31/2019 | 527,659 |
| RTW INVESTMENTS, LP | 10% Owner | 10/30/2019 | 1,193,004 |
| RTW INVESTMENTS, LP | 10% Owner | 10/01/2019 | 693,029 |
| Harrison Seth Loring | Director | 06/21/2019 | 25,000,002 |
| Apple Tree Partners IV, L.P. | 10% Owner | 06/21/2019 | 25,000,002 |
| RTW INVESTMENTS, LP | 10% Owner | 06/19/2019 | 10,000,008 |
Load More Insider Transactions
FUNDS WITH A POSITION IN STOKE THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 3,858,463 | 0.00121% | 87.28% | Other |
| BAKER BROS. ADVISORS LP | 3,368,443 | 0.57% | 65.92% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 639,807 | 0.0008% | 3.91% | Other |
| D. E. SHAW & CO., INC. | 193,760 | 0.00224% | 35.77% | Other |
| PALO ALTO INVESTORS LP | 125,861 | 0.19% | New | Other |
| TUDOR INVESTMENT CORP ET AL | 33,326 | 0.00286% | New | Event Driven, Other |
| RENAISSANCE TECHNOLOGIES LLC | 19,100 | 0.00041% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR STOKE THERAPEUTICS INC
STOCK BUYBACKS FOR STOKE THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
2.84%
1Q
09/30/2023
4.47%
2Q
06/30/2023
4.66%
3Q
03/31/2023
8.72%
4Q
12/31/2022
17.26%
5Q
09/30/2022
17.32%
6Q
06/30/2022
17.80%
7Q
03/31/2022
23.50%
8Q
12/31/2021
25.54%
9Q
09/30/2021
25.81%
10Q
06/30/2021
25.99%
11Q
03/31/2021
26.21%
12Q
12/31/2020
31.80%
13Q
09/30/2020
38.99%
14Q
06/30/2020
39.91%
15Q
03/31/2020
40.58%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR STOKE THERAPEUTICS INC
LOADING...